Closed · W81XWH-09-PCRP-NIA · CFDA 12.420 · Discretionary

FY09 DOD Prostate Cancer New Investigator Award

Federal grant opportunity posted by Defense Health Agency Contracting Activity - DHACA, cataloged on Grants.gov.

Varies
Award range
Closed
Status
May 20, 2009
Close date
23
Expected awards

The verdict

FY09 DOD Prostate Cancer New Investigator Award is a closed discretionary listing from Defense Health Agency Contracting Activity - DHACA that offered Varies by applicant across 23 expected awards. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 1,795 other opportunities from Defense Health Agency Contracting Activity - DHACA.

Varies
award range
Closed
application status
23
expected awards
12.420
CFDA program

Archived opportunity record

FY09 DOD Prostate Cancer New Investigator Awa… is closed (last close May 20, 2009). Check the agency catalog for replacement NOFOs. Defense Health Agency Contracting Activity - DHACA still indexes 1,795 other opportunities here.

According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.

Deadline tracker

Application window closed

Closed May 20, 2009

Posted Feb 10 Closes May 20

Est. Total Funding

$8,300,000

Expected Awards

23

Instrument

Grant

Description

The PCRP New Investigator Award mechanism was introduced in FY99. Since then, 1,826 applications have been received and 388 have been recommended for funding. The New Investigator Award supports independent PIs in the early stages of their careers and requires a designated collaborator. The PCRP seeks PIs who have innovative, high-impact ideas or new technologies applicable to prostate cancer research, prevention, detection, diagnosis, or treatment. The PCRP seeks applications from all areas of basic, preclinical, behavioral, and epidemiological research that are responsive to one or more of the FY09 PCRP focus areas. NOTE: Clinical trials are not allowed under this mechanism. Refer to the Application Instructions and General Information, Appendix 6, for helpful information about distinguishing clinical trials and clinical research. It is the responsibility of the Principal Investigator (PI) to clearly and explicitly articulate how the project addresses the following important aspects of the New Investigator Award: 1. Personnel: The PI and collaborator are emphasized in this award. The PI’s record of accomplishment will be evaluated regarding his or her potential for contributing to the prostate cancer research field. The PI and collaborator together will be emphasized in peer review to determine whether their combined background and prostate cancer-related expertise demonstrate the ability to accomplish the proposed work. 2. Innovation: Innovative research may represent a new paradigm, challenge existing paradigms, or look at existing problems from new perspectives. This may include high-risk approaches to prostate cancer research provided that there is potential for significant impact. Research that is an incremental advance upon published data is not considered innovative and will not be considered for funding under this mechanism. 3. Impact: Research that has high impact will, if successful, significantly advance current methods and concepts for the prevention, detection, diagnosis, or treatment of prostate cancer in humans. 4. Responsiveness to focus areas: The relevance of the research problem to one or more of the FY09 PCRP focus areas. 5. Collaborator: Submission to this award mechanism requires a collaborator (or collaborators), appropriate to the application, who has experience in prostate cancer research, as demonstrated by a record of funding and publications in prostate cancer research. FY09 DOD Prostate Cancer New Investigator Award 4 6. Preliminary Data: To encourage submissions from PIs early in their careers, applications are not required to have preliminary data. Any preliminary data provided should be from the laboratory of the PI or member(s) of the collaborating team. Although groundbreaking research often involves a degree of risk due to unforeseen difficulties or results, applications should be based on a sound scientific rationale that is established through logical reasoning and/or critical review and analysis of the literature. See the Program Announcement for the full Funding Opportunity Description.

Catch-all / unrestricted eligibility mark · W81XWH-09-PCRP-NIA

Grants.gov marks FY09 DOD Prostate Cancer New Investigator Awa… with a catch-all / unrestricted eligibility code (Unrestricted / see official listing). Read the official announcement text for the real applicant filter — the code alone is not a door list. The extract does not mark applicant cost-sharing as required. Instrument: Grant. Funding-activity code maps to Science and Technology / R&D (ST). This eligibility-code string dominates the Defense Health Agency Contracting Activity - DHACA book (1,791 peers, 100% of 1,796).

Code 99
Unrestricted / see official listing

Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil eReceipt HELP: 301-682-5507; help@cdmrp.org

What to do next

FY09 DOD Prostate Cancer New Investigator Awa… is closed; use the parent program and agency catalog for the next funding cycle.

  • Browse open federal opportunities in the same category when this listing is closed. Open opportunities
  • Look up CFDA 12.420 across all indexed listings before you commit to this opportunity alone. Eligibility finder
  • Compare award ranges across federal categories before you pick a single CFDA. All categories

Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants